SCHEMBL9736133

SCHEMBL9736133

CC(C)c1nc2c(c(-c3ccc(F)cc3)c1C=CC=O)c(=O)[nH]c(=O)n2C

nearest known ligand 0.37

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
GCGR P47871 3/20 0.37
TP53 P04637 1/20 0.36
THRB P10828 1/20 0.36
KDM1A O60341 1/20 0.35
IDO1 P14902 1/20 0.35
BRDT Q58F21 1/20 0.35
POLB P06746 1/20 0.35
FYN P06241 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2C19 P33261 1/20 0.34
KMT2A Q03164 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
ALDH1A1 P00352 1/20 0.34
DPP4 P27487 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9736123 1.00 GCGR (0.37) GCGRTP53THRBKDM1AIDO1
SCHEMBL9383734 0.90 GCGR (0.40) GCGRTP53THRBKDM1AIDO1
SCHEMBL9384186 0.87 GCGR (0.38) GCGRTP53ALDH1A1
SCHEMBL9735137 0.87 GCGR (0.38) GCGRTP53ALDH1A1
SCHEMBL9388048 0.86 KDM4E (0.45) GCGRCYP1A2CYP2C19KMT2ASMN1; SMN2
SCHEMBL9736896 0.86 KDM4E (0.45) GCGRCYP1A2CYP2C19KMT2ASMN1; SMN2
SCHEMBL9735571 0.81 GCGR (0.39) GCGRIDO1CYP1A2CYP2C19ALDH1A1
SCHEMBL9383069 0.81 GCGR (0.39) GCGRIDO1CYP1A2CYP2C19ALDH1A1
SCHEMBL7791791 0.79 GCGR (0.40) GCGRSMN1; SMN2ALDH1A1
SCHEMBL9772121 0.79 HMGCR (0.60) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5145959-A Enzyme inhibitors; antilipemic agents; treatment of atherosclerosis BAYER AKTIENGESELLSCHAFT (DE) 1992-09-08 US disclosed
US-5075311-A Anticholesterol agents BAYER AKTIENGESELLSCHAFT (DE) 1991-12-24 US disclosed